The Journal Enfermedades Infecciosas y Microbiología Clínica is the official publication of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) (Spanish Society of Infectious Diseases and Clinical Microbiology). It has as its aim to respond to the challenges currently posed by everything associated with infectious diseases, from a clinical, microbiological and public health perspective.
The Journal follows a rigorous selection process of the manuscripts published through the review by the best experts in each area of knowledge of the specialty. The quality of the material published is the main aim of the Editors, as well as to provide readers with the latest and most relevant information in the world of infectious diseases.
Enfermedades Infecciosas y Microbiología Clínica includes the following sections: original articles, critical reviews, scientific letters, and a section dedicated to continuing medical education, which each year deals with a specific subject and a series of specific topics of the specialty, prepared by invited authors of recognised experience.
The Journal is included in Science Citation Index Expanded, Medline/PubMed, and SCOPUS.
Indexed in:
Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS
See moreFollow us:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2021
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSpecial content about coronavirus SARS-CoV-2 (COVID-19) in Enfermedades Infecciosas y Microbiología Clínica (English Edition)

- Validation of a duplex PCR technique using the gen E and RNase P for the diagnosis of SARS-CoV-2
- Optimization and adaptation of the diagnostic capacity for the performance of large volumes of SARS-CoV-2 RT-PCR
- Changes in the incidence and clinical manifestations of paediatric respiratory infections of viral aetiology during the SARS-CoV-2 pandemic
- Multisystem inflammatory syndrome in adults associated to SARS-CoV-2

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:
SOCIOS PROTECTORES
-
- AbbVie Spain, S.L.U.
- Gilead Sciences, S.L.U.
- Pfizer GEP, S.L.U.
- Vircell Spain, S.L.U.
- Roche Diagnostics, S.L.U.
- Shionogi, S.L.U.
SOCIOS PATROCINADORES
- Abbott
- Accelerate Diagnostics, S.L.
- Angelini Farmacéutica, S.A.
- Becton Dickinson S.A.U.
- Biomerieux España, S,A.U.
- Cepheid Iberia, S.L.U.
- Diasorin
- GSK
- Hologic Iberia, S.L.U.
- Illumina Productos de España, S.L.U.
- Janssen-Cilag, S.A.
- Laboratorios Menarini S.A.
- Laboratorios ViiV Healthcare, S.L.
- Merck Sharp & Dohme de España, S.A.
- Proquinorte
- Roche Farma
- Theratechnologies